4FK-28801-67590
2 vaccinations
11 coded responses
20 check-ins
11 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 272 / NC
- Registered
- 2021-11-13
- Relationship
- Child or adolescent in my care
- Guardian
- EDZ-22560-43351
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-11-13
Registered in v-safe
-
2021-11-13
Dose 1 — Pfizer-BioNTech
-
2021-11-13
Survey response — day 0, dose 1, dependentMedDRA: Nasal congestion, Rhinorrhoea — Feeling: Poor · Site: Pain · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesFree text: Stuffy Runny NoseMedDRA releases: 2024-11 · check-in free text available
-
2021-11-14
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Nasal congestion, Rhinorrhoea — Feeling: Poor · Site: Pain, Swelling · Fever · Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Stuffy Runny NoseMedDRA releases: 2024-11 · check-in free text available
-
2021-11-15
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Lacrimation increased, Nasal congestion, Ocular hyperaemia, Rhinorrhoea — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend schoolFree text: Stuffy Runny Nose with runny red eyesMedDRA releases: 2024-11 · check-in free text available
-
2021-11-17
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Site: Pain, Itching · Fever · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-11-18
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Flank pain — Feeling: Good · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal painFree text: Left side only with achesMedDRA releases: 2024-11 · check-in free text available
-
2021-11-19
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Chills, Joint pains, Fatigue or tirednessAdult check-in
-
2021-11-20
Survey response — day 7, dose 1, dependentMedDRA: Unevaluable event — Feeling: GoodFree text: Individual has Type 1 diabetesMedDRA releases: 2024-11 · check-in free text available
- 2021-11-27
-
2021-12-04
Dose 2 — Pfizer-BioNTech
-
2021-12-05
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain, Redness, Swelling · Fever · NoneAdult check-in
-
2021-12-07
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-12-08
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-12-13
Survey response — day 7, dose 2, dependentMedDRA: Type 1 diabetes mellitus — Feeling: Good · Joint painsFree text: Type 1 diabeticMedDRA releases: 2024-11 · check-in free text available
-
2021-12-18
Survey response — day 14, dose 2, dependentMedDRA: Nasopharyngitis — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Cold like symptoms. Mom is going to test for Covid MondayMedDRA releases: 2024-11 · check-in free text available
-
2021-12-27
Survey response — day 21, dose 2, dependentMedDRA: Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activitiesFree text: Possible covid19 symptoms but no test done because of uncertainty if it was just a cold was hard to tellMedDRA releases: 2024-11 · check-in free text available
- 2022-01-01
- 2022-01-10
-
2022-01-15
Survey response — day 42, dose 2, dependentMedDRA: Body temperature increased, Fatigue — Feeling: Fair · Be unable to work or attend schoolFree text: Covid 19 infection symptoms started 1/9/21 ended 1/14/21 fever 99.5 highest and fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-03-05
Survey response — 3 months, dose 2, dependentMedDRA: Unevaluable event — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Possible 3rd infection of covid at current.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-04
-
2022-12-06
Survey response — 12 months, dose 2, dependentMedDRA: Influenza, Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: RSV 10/15/22 Influenza Type A 11/25/22MedDRA releases: 2024-11 · check-in free text available
-
2022-12-06
Report sent to call center — 12 months, dose 2, dependentBe unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-07
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-13 | Pfizer-BioNTech | No |
| 2 | 2021-12-04 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — day 0, dose 1, dependent
Systemic reaction (other): Stuffy Runny Nose
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Stuffy Runny Nose
Systemic reaction (other): Stuffy Runny Nose with runny red eyes
Systemic reaction (other): Left side only with aches
Release 10 — day 7, dose 1, dependent
Systemic reaction (other): Individual has Type 1 diabetes
Release 10 — day 7, dose 2, dependent
Systemic reaction (other): Type 1 diabetic
Release 10 — day 14, dose 2, dependent
Symptoms: Cold like symptoms. Mom is going to test for Covid Monday
Release 10 — day 21, dose 2, dependent
Symptoms: Possible covid19 symptoms but no test done because of uncertainty if it was just a cold was hard to tell
Release 10 — day 42, dose 2, dependent
Symptoms: Covid 19 infection symptoms started 1/9/21 ended 1/14/21 fever 99.5 highest and fatigue
Release 11 — 3 months, dose 2, dependent
Symptoms: Possible 3rd infection of covid at current.
Release 12 — 12 months, dose 2, dependent
Symptoms: RSV 10/15/22 Influenza Type A 11/25/22
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Flank pain | · | · | ✓ |
| SRO | Lacrimation increased | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Ocular hyperaemia | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Type 1 diabetes mellitus | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release